Lynn Seely Lyell Immunopharma, Inc. (LYEL) insider trading activity

LYEL Quotes by TradingView

Lynn Seely is President and CEO of Lyell Immunopharma, Inc.. Currently has a direct ownership of 712,500 shares of LYEL, which is worth approximately $384,750. The most recent transaction as insider was on Mar 14, 2025, when has been sold 175,000 shares (Common Stock) at a price of $0.61 per share, resulting in proceeds of $106,750. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 713K
256.25% 3M change
256.25% 12M change
Total Value Held $384,750

Lynn Seely Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 14 2025
BUY
Open market or private purchase
$106,750 $0.61 p/Share
175,000 Added 19.72%
712,500 Common Stock
Feb 10 2025
BUY
Grant, award, or other acquisition
-
337,500 Added 38.57%
537,500 Common Stock
Feb 09 2024
BUY
Grant, award, or other acquisition
-
200,000 Added 50.0%
200,000 Common Stock

Also insider at

BPMC
Blueprint Medicines Corp Healthcare
LS

Lynn Seely

President and CEO
Cambridge, MA

Track Institutional and Insider Activities on LYEL

Follow Lyell Immunopharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LYEL shares.

Notify only if

Insider Trading

Get notified when an Lyell Immunopharma, Inc. insider buys or sells LYEL shares.

Notify only if

News

Receive news related to Lyell Immunopharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LYEL